VANDA PHARMACEUTICALS INC (VNDA) Stock Income Statement
NASDAQ:VNDA - Nasdaq - US9216591084 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 198.77M | 192.64M | 254.40M | 268.70M | 248.20M | |||
| Cost Of Goods | 11.31M | 14.80M | 24.30M | 25.60M | 23.40M | |||
| Gross Profit | 187.46M | 177.84M | 230.10M | 243.10M | 224.80M | |||
| Operating Expenses | 228.12M | 191.80M | 223.80M | 181.10M | 190.60M | |||
| Research and Development | 74.43M | 76.82M | 85.80M | 55.60M | 48.70M | |||
| Selling, General, and Administrative Expenses | 146.41M | 112.88M | 136.50M | 124.00M | 140.50M | |||
| Operating Income | -40.66M | -13.95M | 6.30M | 62.00M | 34.10M | |||
| Other Income/Expense | 17.74M | 20.29M | 5.00M | 200.00K | 4.40M | |||
| Non Recurring Items | N/A | N/A | N/A | -19.80M | -6.90M | |||
| Income Before Taxes | -22.92M | 6.34M | 11.30M | 42.40M | 31.70M | |||
| Income Tax | -4.02M | 3.83M | 5.00M | 9.20M | 8.30M | |||
| Net Income | -18.90M | 2.51M | 6.30M | 33.20M | 23.30M | |||
| EBITDA | -32.53M | -10.94M | 9.00M | 64.90M | 37.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.33 | 0.04 | 0.11 | 0.58 | 0.42 | |||
| Non GAAP EPS | -0.32 | 0.05 | 0.12 | 0.58 | 0.43 | |||
| Statistics | ||||||||
| Gross Profit Margin | 94.31% | 92.32% | 90.45% | 90.47% | 90.57% | |||
| Profit Margin | -9.51% | 1.30% | 2.48% | 12.36% | 9.39% | |||
| Operating Profit Margin | -20.46% | -7.24% | 2.48% | 23.07% | 13.74% | |||
All data in USD